Esketamine for treatment-resistant depression submitted to FDA

Janssen Pharmaceuticals announced that the company on September 4th, 2018, submitted a New Drug Application to the US FDA for esketamine nasal spray for treatment-resistant depression.

How Common are Withdrawal and Emotional Blunting in Chronic Antidepressant Treatment?

The problem of withdrawal syndromes and emotional blunting occurring with prolonged antidepressant treatment is constantly underestimated by clinicians.

The Antidepressant Debate in the New York Times

An article on the front page of the New York Times on April 7, 2018, has fueled the debate over antidepressants again.

The Mental Health Crisis in Graduate Education

In the March issue of Nature Biotechnology, Teresa Evans of the University of San Antonio, Texas, and co-authors point out that there is “Evidence for a mental health crisis in graduate education”.

Nutrition: a Mega Theme for Psychiatry of the Future

A brief report from the first congress of the International Society for Nutritional Psychiatry Research (ISNPR), which emphasizes the importance of nutrition.

How medical education creates its own patients

Two overviews in JAMA show that medical students and residents are suffering terrifyingly frequently from depression and depressive symptoms.